AKR1B1 and cancer: Considering that AKR1B1 leads to negative regulation of lysosome trafficking to endosomes and increases the formation of multivesicular bodies (MVBs) in cancer cells (53), the application of drugs such as epalrestat leads to a decrease in metastasis and reduces the amount of exosome production from cancer cells.